According to research presented to the Society of Nuclear Medicine and Molecular Imaging (SNMMI), using a scan for prostate cancer therapy can help in personalizing the treatment. In the two cycles of 177Lu-PSMA radioligand, the study found that prostate-specific membrane antigen (PSMA) PET imaging can help predict survival. Here are the details of the prostate

Multiple Sclerosis (MS) is a disease that damages the central nervous system, thus disrupting communication between the brain and spinal cord. A radiotracer called [F-18] PBR06 can detect changes in brain matter through positron emission tomography (PET). [F-18]PBR06 has the potential to detect the disease before patients show any symptoms giving doctors the ability to

Doctors try to understand the way cells respond to treatments and medical conditions before offering diagnosis and treatment. With research efforts, new ways of studying diseases at cellular levels have been developed. Researchers have come up with a 3D tissue imaging technique known as X-ray histotomography that enables them to study cell details in a

PET-CT scanning is the gold standard for imaging in cancer. It is used for detecting and monitoring all types of cancer. PET-CT technology has improved with time and now offers plenty of benefits in oncology. Today, digital PET-CT scanners provide high image qualities, and radiologists can now detect small cancer lesions and treat the cancer

Computed tomography (CT) scans assist doctors to find tumors, their shape, location, and size. They show a clear cross-section of the body, including soft tissues, blood vessels, organs, and bones. Doctors use CT scans to guide a needle when removing a small tissue during a biopsy and other types of treatments such as radiofrequency ablation.

Positron emission tomography and computed tomography (PET-CT) are two powerful technologies that provide advanced information about a patient’s cancer, its location, anatomy, and activity within the body. Using PET-CT helps to target radiation to a precise cancer location without causing damage to surrounding healthy tissue. It also improves the accuracy of a patient’s diagnosis. PET

Lymphoma is a type of cancer affecting the immune system. It is classified into Hodgkin lymphoma and non-Hodgkin lymphoma. These two types are further categorized into several subtypes. Doctors use PET scans many times in the treatment of lymphoma, starting with determining the stage at which the cancer is, monitoring treatment response and giving a

PET imaging has come a long way, with the first ever PET scanner coming to the fore in 1977. This technology utilizes the energy given off in body processes and turns them into images, highlighting the overactive or problem areas with the help of a radioactive tracer introduced into the body. It is used to

When doctors need to examine the inner workings of the body, they are most likely going to recommend a PET scan. A positron emission tomography (PET) scan shows images of organs and tissues and how they are functioning. It is used in the detection of several diseases including heart disease, cancer and brain disorders. Doctors

PET-CT scans make use of two technologies to tell whether cancer is present and, if yes, where exactly it is located. PET-CT stands for positron emission tomography and computed tomography and is among the best options for cancer imaging. It has gained popularity over the years and has been proven to be useful in determining